Monte Rosa Therapeutics Inc

NASDAQ:GLUE   11:40:26 AM EDT
7.94
+0.16 (+2.06%)
Earnings Announcements

Monte Rosa Says Year-End Cash, Cash Equivalents To Provide Runway Into Late 2024

Published: 03/29/2022 11:44 GMT
Monte Rosa Therapeutics Inc (GLUE) - Monte Rosa Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates.
Monte Rosa Therapeutics Inc - Year-end Cash and Cash Equivalents Expected to Provide Runway Into Late 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.54

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.